According to our new research study on “Tracheostomy Market Forecast to 2031-Global Analysis- by Type, Technique, End User, and Geography,” the market is anticipated to grow from US$ 782.91 million in 2023 and is projected to reach US$ 1.26 billion by 2031; it is expected to register a CAGR of 6.2% during 2023-2031. The increasing prevalence of respiratory diseases and the growing geriatric population are contributing to the growing tracheostomy market size. However, complications associated with tracheostomy hamper the market growth. Further, technological advancements in tracheostomy devices and procedures are expected to bring new tracheostomy market trends in the coming years.
North America accounted for a major share of the global tracheostomy market in 2023. The North America tracheostomy market is segmented into the US, Canada, and Mexico. The US is one of the most developed countries in North America. A tracheostomy is a medical surgery in which the airway is directly accessed by creating a hole in the front of the neck into the trachea. It is frequently carried out in situations involving airway obstruction, respiratory failure, trauma, or extended mechanical ventilation. An article in Critical Care Medicine 2020 states that ~100,000 tracheostomies are performed in the US each year.
Government activities aimed at addressing the product shortage are expected to generate growth opportunities for the market in the near future. The U.S. Food and Drug Administration (FDA) informed patients, caregivers, and healthcare providers in October 2022 that there was a shortage of tracheostomy tubes, particularly ICU Medical's Bivona tracheostomy tubes. Pediatric patients were more likely to be affected by a Bivona tracheostomy tube scarcity since there were not as many substitute tubes available with comparable functioning.
The need for tracheostomy treatments is on the rise due to an increase in the prevalence of chronic respiratory conditions such as asthma, obstructive sleep apnea, and chronic obstructive pulmonary disease (COPD). The Asthma Canada Annual Report 2021 states that over 850,000 children under the age of 14 have asthma, making it one of the most prevalent chronic illnesses in children and a significant contributor to hospitalization and absenteeism from school. Severe asthma, which affects an estimated 150,000-250,000 Canadians.
Improved training programs for medical professionals, such as doctors, nurses, and respiratory therapists, in carrying out and overseeing tracheostomy procedures increased the acceptance rate. Therefore, there is a growing understanding among medical professionals of the advantages of early tracheostomy in critically sick patients, which lowers difficulties related to ventilator use and enhances patient outcomes. Thus, rising rates of respiratory illnesses and increasing awareness of tracheostomy advantages contribute to the market's expansion.
The rising use of tracheostomy operations and devices is partly due to the private healthcare sector in Mexico, which frequently has access to more cutting-edge medical technologies than public facilities. For instance, tracheostomy penetration rates are higher in larger hospitals and specialty clinics in locations such as Guadalajara, Monterrey, and Mexico City. Moreover, the Mexican government has been putting healthcare reforms into effect with the goal of enhancing access to high-quality medical care, which may have a favorable impact on the availability of tracheostomy services throughout the nation. This plan includes growing critical care units and purchasing cutting-edge medical equipment.
This collaboration aims to work together to enhance the care, safety, and quality of life of patients undergoing tracheostomy. The 8th International Symposium by GTC will be conducted in November 2024 and will focus on delivering safe, effective tracheostomy care on a global scale, achieved through data-driven innovations of interprofessional teams of physicians, nurses, respiratory therapists, speech therapists, patients, and families.
Further, global tracheostomy tube awareness week was conducted from May 15-21 in 2022 by the Tracheostomy Education institution. The campaign aimed at increasing awareness about individuals with tracheostomy among their families and caregivers across the globe. In addition, the Joint Faculty of Intensive Care Medicine of Ireland conducted National Critical Care Tracheostomy Day on January 17, 2024, which aimed to provide education on multidisciplinary care, best practices, and insights from experts in the field of tracheostomy.
The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and American Society for Clinical Trials are among the primary and secondary sources referred to while preparing the tracheostomy market report.
North America accounted for a major share of the global tracheostomy market in 2023. The North America tracheostomy market is segmented into the US, Canada, and Mexico. The US is one of the most developed countries in North America. A tracheostomy is a medical surgery in which the airway is directly accessed by creating a hole in the front of the neck into the trachea. It is frequently carried out in situations involving airway obstruction, respiratory failure, trauma, or extended mechanical ventilation. An article in Critical Care Medicine 2020 states that ~100,000 tracheostomies are performed in the US each year.
Government activities aimed at addressing the product shortage are expected to generate growth opportunities for the market in the near future. The U.S. Food and Drug Administration (FDA) informed patients, caregivers, and healthcare providers in October 2022 that there was a shortage of tracheostomy tubes, particularly ICU Medical's Bivona tracheostomy tubes. Pediatric patients were more likely to be affected by a Bivona tracheostomy tube scarcity since there were not as many substitute tubes available with comparable functioning.
The need for tracheostomy treatments is on the rise due to an increase in the prevalence of chronic respiratory conditions such as asthma, obstructive sleep apnea, and chronic obstructive pulmonary disease (COPD). The Asthma Canada Annual Report 2021 states that over 850,000 children under the age of 14 have asthma, making it one of the most prevalent chronic illnesses in children and a significant contributor to hospitalization and absenteeism from school. Severe asthma, which affects an estimated 150,000-250,000 Canadians.
Improved training programs for medical professionals, such as doctors, nurses, and respiratory therapists, in carrying out and overseeing tracheostomy procedures increased the acceptance rate. Therefore, there is a growing understanding among medical professionals of the advantages of early tracheostomy in critically sick patients, which lowers difficulties related to ventilator use and enhances patient outcomes. Thus, rising rates of respiratory illnesses and increasing awareness of tracheostomy advantages contribute to the market's expansion.
The rising use of tracheostomy operations and devices is partly due to the private healthcare sector in Mexico, which frequently has access to more cutting-edge medical technologies than public facilities. For instance, tracheostomy penetration rates are higher in larger hospitals and specialty clinics in locations such as Guadalajara, Monterrey, and Mexico City. Moreover, the Mexican government has been putting healthcare reforms into effect with the goal of enhancing access to high-quality medical care, which may have a favorable impact on the availability of tracheostomy services throughout the nation. This plan includes growing critical care units and purchasing cutting-edge medical equipment.
Growing Number of Initiatives and Awareness Programs to Provide Market Opportunities in Future
A few government initiatives are focused on improving accessibility and promoting innovation in the field of tracheostomy. For instance, the Global Tracheostomy Collaborative (GTC) is a quality improvement collaborative that offers the best tracheostomy care across the globe and helps staff, managers, patients, and their families rapidly implement the best practices into healthcare settings.This collaboration aims to work together to enhance the care, safety, and quality of life of patients undergoing tracheostomy. The 8th International Symposium by GTC will be conducted in November 2024 and will focus on delivering safe, effective tracheostomy care on a global scale, achieved through data-driven innovations of interprofessional teams of physicians, nurses, respiratory therapists, speech therapists, patients, and families.
Further, global tracheostomy tube awareness week was conducted from May 15-21 in 2022 by the Tracheostomy Education institution. The campaign aimed at increasing awareness about individuals with tracheostomy among their families and caregivers across the globe. In addition, the Joint Faculty of Intensive Care Medicine of Ireland conducted National Critical Care Tracheostomy Day on January 17, 2024, which aimed to provide education on multidisciplinary care, best practices, and insights from experts in the field of tracheostomy.
Tracheostomy Market: Competitive Landscape and Key Developments
Medtronic Plc, ICU Medical Inc, Coloplast Corp, Fisher & Paykel Healthcare Corp Ltd, Teleflex Inc, Cook Medical Holdings LLC, Troge Medical GmbH, Fuji Systems Corp, Andreas Fahl Medizintechnik-Vertrieb GmbH, Medis Medical (Tianjin) Company Ltd, Boston Medical Products, Well Lead Medical Co. Ltd., Intersurgical Ltd, KAPITEX Healthcare Ltd, VBM Medizintechnik GmbH, SunMed Group Holdings LLC, AdvaCare Pharma USA LLC, and Angiplast Private Limited are among the key companies operating in the tracheostomy market.The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and American Society for Clinical Trials are among the primary and secondary sources referred to while preparing the tracheostomy market report.
Reasons to buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the tracheostomy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the tracheostomy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the tracheostomy market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Tracheostomy Market Landscape
5. Tracheostomy Market - Key Market Dynamics
6. Tracheostomy Market - Global Market Analysis
7. Tracheostomy Market Analysis - by Type
8. Tracheostomy Market Analysis - by Technique
9. Tracheostomy Market Analysis - by End User
10. Tracheostomy Market - Geographical Analysis
11. Tracheostomy Market - Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned
Some of the leading companies in the Tracheostomy Market- Medtronic Plc
- ICU Medical Inc
- Coloplast Corp
- Fisher & Paykel Healthcare Corp Ltd
- Teleflex Inc
- Cook Medical Holdings LLC
- Troge Medical GmbH
- Fuji Systems Corp
- Andreas Fahl Medizintechnik-Vertrieb GmbH
- Medis Medical (Tianjin) Company Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 164 |
| Published | October 2024 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value ( USD | $ 782.91 Million |
| Forecasted Market Value ( USD | $ 1263.65 Million |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
